Supporting European Science
We mobilise philanthropic capital and accelerate important medical research.
How do you stay sharp into old age?
Some people reach 100 and remain perfectly sharp. With the CENTURY-BRAIN Initiative, Prof. Henne Holstege is investigating how their brains stay protected against dementia. It is the first research Lenos Foundation supports.
“Ik moet zeggen dat ik in mijn hele carrière niks heb gezien in het veld dat zo vernieuwend was.”
What Scientists Say
To form this picture, we spoke with leading scientists who know the field.
“Highly competitive and complex grant schemes often have a very unfortunate relation between effort and expected value per participating researcher. In the worst case, the combined time investment of the applicants may exceed the total grant budget.” “Ik zou meer geld naar fundamentele wetenschap schuiven. Daar zijn universiteiten uniek in. De start van ieder nieuw geneesmiddel was toch eigenlijk een nieuw inzicht dat uit een van de universiteiten wereldwijd kwam.” “Dit systeem maakt dat onderzoekers wellicht minder snel geneigd zijn om aan fundamentele nieuwe dingen te werken, omdat het dan moeilijker is om geld binnen te krijgen.” “Er wordt een prikkel gecreëerd om weinig controversiële voorstellen te honoreren. Dingen die als een beetje risicovol gezien worden, zijn de eerste voorstellen die sneuvelen. Het leidt tot een beetje kokervisie.” “Langjarige financiële continuïteit is essentieel om baanbrekend wetenschappelijk onderzoek te laten renderen en om innovaties naar de markt te brengen. […] Dit wisselvallig beleid leidt tot verspilling van investeringen.” “The scale, depth and scientific rigor of this cohort make it an important resource for understanding the factors that contribute to resilience and exceptional longevity. As one of the most unique datasets of its kind, it has the potential to generate important insights into healthy aging and resilience to neurodegenerative disease. We've already seen firsthand the value of this research in informing scientific discovery, and continued investment in this work could benefit the broader research community for years to come.” Why We Do This
The world’s greatest discoveries come from fundamental research: the work of scientists who dare to be curious without knowing in advance where it will lead. Without it there would be no CRISPR-Cas, no mRNA vaccines and no cancer immunotherapy, all Nobel Prize-winning research. The World Wide Web and ASML began this way too. And the multi-billion market for Ozempic and Wegovy started with a question about the venom of a lizard.
Around 10%, or even less: that is the chance that a proposal for fundamental research above €1.5 million is funded, even when it has been rated highly.
Unpredictable work is hard to fund
Researchers depend on their university and on a range of funds. They move from proposal to proposal, year after year. All that writing time is not spent on research, and it slows exactly the work that yields the most.
The system works against fundamental research
Concrete plans with quick results stand a better chance of funding than open, curiosity-driven research. Universities often have to co-fund to secure money from a fund. The system thus pushes researchers towards quick wins, while it should exist precisely for the major breakthroughs. Companies only step in once results are concrete; the long run-up has to come from science itself.
Enough money, but fragmented
The Netherlands and Europe do invest in research, but spread across 27 countries: 94% national, 6% European. In the United States, 96% comes from a single federal budget, supplemented by large philanthropic foundations. The Netherlands has no equivalent. We rank among the world’s best in publications, yet we do not reach the agreed 3% of GDP for research. Draghi and Wennink reach the same conclusion: fundamental research deserves far greater investment, for the future prosperity of the Netherlands and Europe.
What We Do
We help accelerate researchers working on fundamental research whose breakthroughs can change the world. They do the kind of work other scientists and companies can build on, and from which strong solutions for Europe and the European economy can grow. We focus on research that can help people live longer, healthier lives.
We put funding on the table, but we go further: our aim is for research to stand on its own feet and for its value to flow back to science. So that the next breakthrough does not have to start again with a grant application.
Our Approach
Rigorous research selection through internal due diligence
Active adoption and acceleration
Transparent progress and accountability
ANBI Details
3625 AH, Breukeleveen
Nederland
Treasurer
Gijs Nagel
Chair
Gert Jan Holstege
Secretary
Board
Lenos Foundation maintains a governance structure that follows the guidelines for good governance of charitable organisations.
Our board members receive no compensation.
Lenos Foundation
We are a non-profit foundation established by the team behind Lenos Equity. Here, we use our proven expertise in due diligence and scaling to support European research.
Get In Touch
Do you have questions about our research projects, want to become a partner, or have a press enquiry? We would be pleased to hear from you.